252 related articles for article (PubMed ID: 29415485)
1. Experimental in Vivo Models of Candidiasis.
Segal E; Frenkel M
J Fungi (Basel); 2018 Feb; 4(1):. PubMed ID: 29415485
[TBL] [Abstract][Full Text] [Related]
2. Models hosts for the study of oral candidiasis.
Junqueira JC
Adv Exp Med Biol; 2012; 710():95-105. PubMed ID: 22127889
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity of Candida albicans isolates from bloodstream and mucosal candidiasis assessed in mice and Galleria mellonella.
Frenkel M; Mandelblat M; Alastruey-Izquierdo A; Mendlovic S; Semis R; Segal E
J Mycol Med; 2016 Mar; 26(1):1-8. PubMed ID: 26852192
[TBL] [Abstract][Full Text] [Related]
4. The Use of Galleria mellonella Larvae to Study the Pathogenicity and Clonal Lineage-Specific Behaviors of the Emerging Fungal Pathogen Candida auris.
Borman AM
Methods Mol Biol; 2022; 2517():287-298. PubMed ID: 35674963
[TBL] [Abstract][Full Text] [Related]
5. Virulence of
Hernando-Ortiz A; Mateo E; Perez-Rodriguez A; de Groot PWJ; Quindós G; Eraso E
Virulence; 2021 Dec; 12(1):1063-1075. PubMed ID: 33843456
[No Abstract] [Full Text] [Related]
6. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
Scorzoni L; de Lucas MP; Mesa-Arango AC; Fusco-Almeida AM; Lozano E; Cuenca-Estrella M; Mendes-Giannini MJ; Zaragoza O
PLoS One; 2013; 8(3):e60047. PubMed ID: 23555877
[TBL] [Abstract][Full Text] [Related]
7. Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
Mannala GK; Rupp M; Walter N; Scholz KJ; Simon M; Riool M; Alt V
J Orthop Res; 2023 Nov; 41(11):2547-2559. PubMed ID: 37080929
[TBL] [Abstract][Full Text] [Related]
8. The Galleria mellonella Waxworm Infection Model for Disseminated Candidiasis.
Dunn MJ; Woodruff AL; Anderson MZ
J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507902
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; Ruiz-Saurí A; Ruiz-Gaitán A; Sigona-Giangreco IA; Cabañero-Navalon MD; Sabalza-Baztán O; Salavert-Lletí M; Tormo MÁ; Pemán J
Microbiol Spectr; 2021 Sep; 9(1):e0001321. PubMed ID: 34106570
[TBL] [Abstract][Full Text] [Related]
10. Candidiasis by
Hernando-Ortiz A; Eraso E; Quindós G; Mateo E
J Fungi (Basel); 2021 Nov; 7(12):. PubMed ID: 34946981
[No Abstract] [Full Text] [Related]
11. Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis.
Xin H; Rosario-Colon JA; Eberle K
mSphere; 2023 Feb; 8(1):e0058422. PubMed ID: 36688668
[TBL] [Abstract][Full Text] [Related]
12. Experimental Mouse Models of Disseminated Candida auris Infection.
Xin H; Mohiuddin F; Tran J; Adams A; Eberle K
mSphere; 2019 Sep; 4(5):. PubMed ID: 31484737
[TBL] [Abstract][Full Text] [Related]
13. Repurposing Pilocarpine Hydrochloride for Treatment of Candida albicans Infections.
Nile C; Falleni M; Cirasola D; Alghamdi A; Anderson OF; Delaney C; Ramage G; Ottaviano E; Tosi D; Bulfamante G; Morace G; Borghi E
mSphere; 2019 Jan; 4(1):. PubMed ID: 30674648
[TBL] [Abstract][Full Text] [Related]
14. Caenorhabditis elegans as a Model System To Assess Candida glabrata,
Hernando-Ortiz A; Mateo E; Ortega-Riveros M; De-la-Pinta I; Quindós G; Eraso E
Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32718968
[TBL] [Abstract][Full Text] [Related]
15. The Galleria mellonella infection model as a system to investigate the virulence of Candida auris strains.
Romera D; Aguilera-Correa JJ; García-Coca M; Mahillo-Fernández I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
Pathog Dis; 2020 Nov; 78(9):. PubMed ID: 33098293
[TBL] [Abstract][Full Text] [Related]
16. Drosophila melanogaster as a Rapid and Reliable In Vivo Infection Model to Study the Emerging Yeast Pathogen Candida auris.
Wurster S; Albert ND; Kontoyiannis DP
Methods Mol Biol; 2022; 2517():299-316. PubMed ID: 35674964
[TBL] [Abstract][Full Text] [Related]
17. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
[TBL] [Abstract][Full Text] [Related]
18. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
19. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
Croxtall JD; Plosker GL
Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
[TBL] [Abstract][Full Text] [Related]
20. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
